Integrated Diagnostics Holdings PLC Notice of Results (8950E)
November 11 2020 - 1:00AM
UK Regulatory
TIDMIDHC
RNS Number : 8950E
Integrated Diagnostics Holdings PLC
11 November 2020
Integrated Diagnostics Holdings Plc Notice of results
11 November 2020
(London) - Integrated Diagnostics Holdings ("IDH," "the Group,"
or "the Company"), IDHC on the London Stock Exchange, a leading
consumer healthcare company with operations in Egypt, Jordan, Sudan
and Nigeria, will publish its unaudited results for the nine-month
period ended 30 September 2020 on Thursday, 19 November 2020 at 7am
(UK).
An analyst and investor call will be hosted at 1pm (UK) | 3pm
(Egypt) on Thursday, 19 November 2020. You may register for the
call through this link . Once the registration is complete, you
will receive a confirmation email containing personal Zoom meeting
details.
Contact
IDH
Nancy Fahmy +20 (0)12 2255 7445
Investor Relations Director nancy.fahmy@idhcorp.com
About Integrated Diagnostics Holdings
IDH is a leading consumer healthcare company in the Middle East
and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The
Group's core brands include Al Borg, Al Borg Scan and Al Mokhtabar
in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar
Sudan (both in Sudan) and Echo-Scan (Nigeria). A long track record
for quality and safety has earned the Company a trusted reputation,
as well as internationally recognised accreditations for its
portfolio of over 1,400 diagnostics tests. From its base of 471
branches as of 30 September 2020, IDH will continue to add
laboratories through a Hub, Spoke and Spike business model that
provides a scalable platform for efficient expansion. Beyond
organic growth, the Group's expansion plans include acquisitions in
new Middle Eastern and African markets where its model is
well-suited to capitalise on similar healthcare and consumer trends
and capture a significant share of fragmented markets. IDH has been
a Jersey-registered entity with a Standard Listing on the Main
Market of the London Stock Exchange (ticker: IDHC) since May
2015.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORGZMMMNGFGGZM
(END) Dow Jones Newswires
November 11, 2020 02:00 ET (07:00 GMT)
Integrated Diagnostics (LSE:IDHC)
Historical Stock Chart
From Apr 2024 to May 2024
Integrated Diagnostics (LSE:IDHC)
Historical Stock Chart
From May 2023 to May 2024